01/24/2020 | Press release | Distributed by Public on 01/24/2020 16:04
January 24, 2020
With a world where the population expected to grow to 9 billion by 2050, the demand for protein is rising. Cargill is investing and innovating broadly across our global supply chain - in animal and alternative protein.
To date, our investments in cultured protein include 2017 and 2020 investments inMemphis Meats, a U.S.-based leader in cultured protein products. In 2019 we also invested inAleph Farms, an Israel-based cell-cultured protein company focused on growing complex meat varieties like steak.
This complements investments in plant-based protein likePURIS, North America's largest producer of pea protein. We also make specialty sweeteners and texturizers for plant-based dairy alternatives.
"Our strategy is to invest in all forms of protein," saidBrian Sikeswho leads Cargill's global protein businesses. "Our cell-cultured protein and plant-based investments will continue to complement the $1.5 billion we have invested in animal protein over the last three years. Keeping all options on the table will help feed people and deliver great-tasting protein for our customers."